Recall inflammatory skin reaction after use of pegylated liposomal doxorubicin in site of previous drug extravasation.
Saini
Andrea
A
Medical Oncology Department, University of Turin, San Luigi di Orbassano Hospital, Gonzole Region 10, 10043 Orbassano, Turin, Italy.
Berruti
Alfredo
A
Sperone
Paola
P
Bitossi
Raffaella
R
Tampellini
Marco
M
Dogliotti
Luigi
L
Gorzegno
Gabriella
G
D000970:Antineoplastic Agents / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects / Q000031:analogs & derivatives*; D003875:Drug Eruptions / Q000209:etiology*; D005119:Extravasation of Diagnostic and Therapeutic Materials / Q000150:complications*; D005260:Female; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D011092:Polyethylene Glycols / Q000009:adverse effects*; D013997:Time Factors
D000970:Antineoplastic Agents; C506643:liposomal doxorubicin; D011092:Polyethylene Glycols; D004317:Doxorubicin